$CRDF

$0.88 +$0.07 (8.8%) Close

$CRDF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 77.8M shares outstanding

Who owns CRDF?

By type of holder

Institutions 23.9% Insiders 5.2% Everyone else 70.9%

Concentration Top 10 holders own 22.0%

BlackRock, Inc. 1.3% · Pace Gary W 4.9%

Institutional ownership

23.9%

-7.7 pts vs last qtr

Institutional holders

103

-14 vs last qtr

Net shares bought

−6.0M

by institutions in Q2 2026

New / sold out

20 / 34

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Jane Street Group, LLC +567.8K
Laurion Capital Management LP +451.6K

Biggest sellers in Q2 2026

BlackRock, Inc. −3.0M
Acorn Capital Advisors, LLC SOLD OUT −1.8M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Cardiff Oncology, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2017–FY2025

+13776.9%

+102.32% a year

Each share's claim on the business

−99.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $30.4M

over 8 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years33% 3–5 years9% 1–3 years38% Under 1 year20%

Quarterly turnover

25.9%

of institutional shares changed hands

Top 10 managers, median time held

4.8 years

Super Investors

Investment managers reporting CRDF on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	972.9K	1.25%	−3.0M (−75.6%)	≤2021	0.0%
Shares held by quarter Peak holding4.0M (Q4'25) Change over 8 quarters−1.8M Share of the company1.250% BlackRock, Inc.'s full portfolio →
LC Laurion Capital Management LP	3.1M	3.98%	+451.6K (+17.1%)	2024	0.1%
Shares held by quarter Peak holding3.1M (Q2'26) Change over 8 quarters+3.1M Share of the company3.980% Laurion Capital Management LP's full portfolio →

BlackRock, Inc.

972.9K

% of company

1.25%

Change vs last qtr

−3.0M (−75.6%)

Held since

≤2021

Laurion Capital Management LP

3.1M

% of company

3.98%

Change vs last qtr

+451.6K (+17.1%)

Held since

2024

28 more super investors behind a free account

See every manager holding Cardiff Oncology, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting CRDF on Form N-PORT; together they hold 10.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$2.7M	2.1M	2.66%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$2.49M	1.5M	1.97%	0.00%	March 31, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$2.7M

% of company

2.66%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$2.49M

% of company

1.97%

% of the fund

0.00%

As of

March 31, 2026

23 more funds behind a free account

See every fund holding Cardiff Oncology, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
PG Pace Gary W Insider	3.8M	4.93%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company4.930% Pace Gary W's insider activity →
LJ Levine James E. Insider	127.7K	0.16%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.160% Levine James E.'s insider activity →

Pace Gary W

Insider

3.8M

% of company

4.93%

Change vs last qtr

—

Held since

—

Levine James E.

Insider

127.7K

% of company

0.16%

Change vs last qtr

—

Held since

—

4 more holders behind a free account

See every insider and 5%+ holder of Cardiff Oncology, Inc..

Comments